Literature DB >> 26597205

Trained immunity: A smart way to enhance innate immune defence.

Jos W M van der Meer1, Leo A B Joosten2, Niels Riksen2, Mihai G Netea2.   

Abstract

The innate arm of the immune system is generally viewed as primitive and non-specific and - in contrast to the adaptive immune arm - not to possess memory. However in plants and invertebrate animals that lack adaptive immunity, innate immunity will exhibit a prolonged enhanced functional state after adequate priming. A similar enhancement of function of the innate immunity has occasionally been described in vertebrates, including humans. Over the past few years we have studied this phenomenon in greater detail and we have coined the term 'Trained (innate) immunity' (TI). TI can be induced by a variety of stimuli, of which we have studied BCG and β-glucan in greater detail. The non-specific protective effects of BCG that have been observed in vaccination studies in the literature are probably due to TI. Monocytes and macrophages are among the main cells of the innate immune arm that can be trained. We have discovered that both BCG (via NOD2 signalling) and β-glucan (via dectin-1) induce epigenetic reprogramming, in particular stable changes in histone trimethylation at H3K4. These epigenetic changes lead to cellular activation, enhanced cytokine production and a change in the metabolic state of the cell with a shift from oxidative phosphorylation to aerobic glycolysis. TI is not only important for host defence and vaccine responses, but most probably also for diseases like atherosclerosis. Modulation of TI is a promising area for new treatments.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  BCG; Candida; Epigenetics; Innate immunity; Trained immunity; Vaccination

Mesh:

Substances:

Year:  2015        PMID: 26597205     DOI: 10.1016/j.molimm.2015.06.019

Source DB:  PubMed          Journal:  Mol Immunol        ISSN: 0161-5890            Impact factor:   4.407


  50 in total

1.  Impaired phagocytosis directs human monocyte activation in response to fungal derived β-glucan particles.

Authors:  Giorgio Camilli; Elif Eren; David L Williams; Vishukumar Aimanianda; Etienne Meunier; Jessica Quintin
Journal:  Eur J Immunol       Date:  2018-02-05       Impact factor: 5.532

Review 2.  Innate immunity as a target for acute cardioprotection.

Authors:  Coert J Zuurbier; Antonio Abbate; Hector A Cabrera-Fuentes; Michael V Cohen; Massimo Collino; Dominique P V De Kleijn; James M Downey; Pasquale Pagliaro; Klaus T Preissner; Masafumi Takahashi; Sean M Davidson
Journal:  Cardiovasc Res       Date:  2019-06-01       Impact factor: 10.787

3.  Transient Immune Activation in BCG-Vaccinated Infant Rhesus Macaques Is Not Sufficient to Influence Oral Simian Immunodeficiency Virus Infection.

Authors:  Matthew P Wood; Lianna F Wood; Megan Templeton; Bridget Fisher; Adriana Lippy; Chloe I Jones; Cecilia S Lindestam Arlehamn; Alessandro Sette; James T Fuller; Patience Murapa; Heather B Jaspan; Deborah H Fuller; Donald L Sodora
Journal:  J Infect Dis       Date:  2020-06-16       Impact factor: 5.226

4.  Mucosal vaccine efficacy against intrarectal SHIV is independent of anti-Env antibody response.

Authors:  Yongjun Sui; George K Lewis; Yichuan Wang; Kurt Berckmueller; Blake Frey; Amiran Dzutsev; Diego Vargas-Inchaustegui; Venkatramanan Mohanram; Thomas Musich; Xiaoying Shen; Anthony DeVico; Timothy Fouts; David Venzon; James Kirk; Robert C Waters; James Talton; Dennis Klinman; John Clements; Georgia D Tomaras; Genoveffa Franchini; Marjorie Robert-Guroff; Giorgio Trinchieri; Robert C Gallo; Jay A Berzofsky
Journal:  J Clin Invest       Date:  2019-02-18       Impact factor: 14.808

5.  Mycobacteria Manipulate G-Protein-Coupled Receptors to Increase Mucosal Rac1 Expression in the Lungs.

Authors:  Nader Alaridah; Nataliya Lutay; Erik Tenland; Anna Rönnholm; Oskar Hallgren; Manoj Puthia; Gunilla Westergren-Thorsson; Gabriela Godaly
Journal:  J Innate Immun       Date:  2016-12-24       Impact factor: 7.349

6.  Schistosomiasis Induces Persistent DNA Methylation and Tuberculosis-Specific Immune Changes.

Authors:  Andrew R DiNardo; Tomoki Nishiguchi; Emily M Mace; Kimal Rajapakshe; Godwin Mtetwa; Alexander Kay; Gugu Maphalala; W Evan Secor; Rojelio Mejia; Jordan S Orange; Cristian Coarfa; Kapil N Bhalla; Edward A Graviss; Anna M Mandalakas; George Makedonas
Journal:  J Immunol       Date:  2018-05-11       Impact factor: 5.422

7.  Age-Specific Differences in the Severity of COVID-19 Between Children and Adults: Reality and Reasons.

Authors:  Amir Tajbakhsh; Khojaste Rahimi Jaberi; Seyed Mohammad Gheibi Hayat; Mehrdad Sharifi; Thomas P Johnston; Paul C Guest; Mohammad Jafari; Amirhossein Sahebkar
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  A Combination of Recombinant Mycobacterium bovis BCG Strains Expressing Pneumococcal Proteins Induces Cellular and Humoral Immune Responses and Protects against Pneumococcal Colonization and Sepsis.

Authors:  Cibelly Goulart; Dunia Rodriguez; Alex I Kanno; Thiago Rojas Converso; Ying-Jie Lu; Richard Malley; Luciana C C Leite
Journal:  Clin Vaccine Immunol       Date:  2017-10-05

9.  Signaling via pattern recognition receptors NOD2 and TLR2 contributes to immunomodulatory control of lethal pneumovirus infection.

Authors:  Tyler A Rice; Todd A Brenner; Caroline M Percopo; Michelle Ma; Jesse D Keicher; Joseph B Domachowske; Helene F Rosenberg
Journal:  Antiviral Res       Date:  2016-06-14       Impact factor: 5.970

10.  Host and Environmental Factors Influencing Individual Human Cytokine Responses.

Authors:  Rob Ter Horst; Martin Jaeger; Sanne P Smeekens; Marije Oosting; Morris A Swertz; Yang Li; Vinod Kumar; Dimitri A Diavatopoulos; Anne F M Jansen; Heidi Lemmers; Helga Toenhake-Dijkstra; Antonius E van Herwaarden; Matthijs Janssen; Renate G van der Molen; Irma Joosten; Fred C G J Sweep; Johannes W Smit; Romana T Netea-Maier; Mieke M J F Koenders; Ramnik J Xavier; Jos W M van der Meer; Charles A Dinarello; Norman Pavelka; Cisca Wijmenga; Richard A Notebaart; Leo A B Joosten; Mihai G Netea
Journal:  Cell       Date:  2016-11-03       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.